Keywords: Breast, Gradients, Gradient Non linearity
Motivation: Improve accuracy of ADC measurement by correcting spatial nonuniformity of diffusion weighting caused by gradient nonlinearity (GNL) using novel vendor implemented on-scanner tools
Goal(s): Evaluate GNL correction of breast tumor ADC in a treatment response study
Approach: Implement on-scanner GNL correction, evaluate uncorrected and corrected tumor ADCs, evaluate GNL bias and ADC changes pre-treatment and post one cycle of neoadjuvant chemotherapy.
Results: Preliminary results from this study indicate adequate performance of the vendor implemented GNL correction of ADC in breast DWI assessment of response to neoadjuvant chemotherapy.
Impact: This pilot study demonstrates vendor-implemented GNL-correction (GNC) of spatially dependent b-value bias can dramatically simplify the process of obtaining more accurate ADC measures, which can improve robustness of ADC as a biomarker for treatment response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords